Journal: PLOS One
Article Title: Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells
doi: 10.1371/journal.pone.0340295
Figure Lengend Snippet: In p53 +/+ cells, hypoxia downregulates CerS2, 4, 6 and DEGS1. It also inhibits SK1 leading to apoptosis. However, in the absence of p53, CerS2 and 4 expression is sustained along with that of DEGS1. As a result, different ceramide species accumulate, particularly long and very long chain ceramides, of which C24:0 ceramide is the most abundant and promoting beside the low sphingosine levels to cell survival in response to oxygen deficit. Combined inhibition of DEGS1 and SK1 or treatment of HCT116 cells with sphingosine or C6 ceramide typically restored p53-like functions in p53-deficient cells exposed to hypoxia and sensitized these cells to hypoxia-induced apoptosis.
Article Snippet: The human colon cancer cell line HCT116 p53 +/+ (p53 wild-type, or p53-proficient) was purchased from the American Tissue Culture Collection, ATCC, Manassas, VA.
Techniques: Expressing, Inhibition